Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06250751 | Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate Ca(BETR-PC) | completed | N/A | 27 | Virginia Commonwealth UniversityOTHER | 1 | Oct 31, 2025 | clinicaltrials |
| NCT03480646 | ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer | completed | Phase 1 / Phase 2 | 175 | Constellation PharmaceuticalsINDUSTRY | 1 | Oct 29, 2025 |
| clinicaltrials |
| NCT02203695 | Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy | completed | Phase 2 | 86 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 28, 2025 | clinicaltrials |
| NCT02294461 | An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants | completed | Phase 3 | 395 | Astellas Pharma IncINDUSTRY | 4 | Oct 24, 2025 | clinicaltrials |
| NCT07220499 | Whole Food Plant-based Diet to Improve Outcomes in Prostate Cancer | completed | N/A | 11 | Pacific Cancer CareOTHER | 1 | Oct 24, 2025 | clinicaltrials |
| NCT04838613 | Study of Diagnostic Performance of [18F]CTT1057 in BCR(GuidePath) | completed | Phase 3 | 190 | Novartis PharmaceuticalsINDUSTRY | 4 | Oct 20, 2025 | clinicaltrials |
| NCT02141438 | Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer(REASSURE) | completed | — | 1,472 | BayerINDUSTRY | 20 | Oct 16, 2025 | clinicaltrials |
| NCT03507608 | Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression | completed | Early Phase 1 | 25 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 16, 2025 | clinicaltrials |
| NCT03580499 | Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy | completed | N/A | 43 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT03939689 | I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).(ARROW) | completed | Phase 2 | 120 | Progenics Pharmaceuticals, Inc.INDUSTRY | 2 | Oct 14, 2025 | clinicaltrials |
| NCT03253744 | Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy | completed | Phase 1 | 17 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2025 | clinicaltrials |
| NCT04838626 | Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection(GuideView) | completed | Phase 2 / Phase 3 | 195 | Novartis PharmaceuticalsINDUSTRY | 5 | Oct 7, 2025 | clinicaltrials |
| NCT07206693 | Impact of PSA-based Screening on Mortality Among Men Aged 75-79: Target Trial Emulation | completed | — | 257,275 | Karolinska InstitutetOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT05755490 | PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care Intervention | completed | N/A | 14 | Massachusetts General HospitalOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT06199050 | The Effect of 360° Virtual Reality Movies on Fear and Anxiety(ENGAGE) | completed | N/A | 292 | Maastricht Radiation OncologyOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT03493945 | Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) | completed | Phase 1 / Phase 2 | 59 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2025 | clinicaltrials |
| NCT03516812 | Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer | completed | Phase 2 | 36 | University of WashingtonOTHER | 1 | Sep 29, 2025 | clinicaltrials |
| NCT06520449 | 68Ga-NTA-476 Imaging in Prostate Cancer(NTA-476) | completed | Early Phase 1 | 10 | Melbourne Theranostic Innovation CentreNETWORK | 1 | Sep 25, 2025 | clinicaltrials |
| NCT04158245 | 18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies | completed | Phase 2 | 9 | Tulane UniversityOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT04186845 | Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence | completed | Phase 3 | 391 | Blue Earth DiagnosticsINDUSTRY | 3 | Sep 22, 2025 | clinicaltrials |
| NCT05819606 | Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer Patients(PER2PSMA) | completed | — | 70 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT05323747 | Prospective Evaluation of a Commercially Available Hydrogel Spacer(BP-008) | completed | — | 20 | BioProtectINDUSTRY | 1 | Sep 16, 2025 | clinicaltrials |
| NCT05354427 | Retrospective Evaluation of Commercial Spacers in Prostate Cancer Patients(CLP-10095) | completed | — | 175 | BioProtectINDUSTRY | 2 | Sep 16, 2025 | clinicaltrials |
| NCT03098836 | Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer(PANTHER) | completed | Phase 2 | 93 | Daniel George, MDOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT05230251 | Radioligand fOr locAl raDiorecurrent proStaTe cancER(ROADSTER) | completed | Phase 1 / Phase 2 | 3 | Glenn BaumanOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT03344757 | Health Gatherings - For Your Health After Cancer | completed | N/A | 188 | University of MiamiOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT06461416 | A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework | completed | N/A | 30 | University of ArkansasOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT07014488 | A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects | completed | Phase 1 | 16 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Sep 10, 2025 | clinicaltrials |
| NCT04272216 | An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres(RAVI Registry) | completed | — | 99 | Terumo Medical CorporationINDUSTRY | 1 | Sep 9, 2025 | clinicaltrials |
| NCT05590793 | Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate | completed | Phase 3 | 195 | IpsenINDUSTRY | 1 | Sep 9, 2025 | clinicaltrials |
| NCT07161778 | A Trial of Triamcinolone With a GnRH Analog for Castration Resistant Prostate Cancer(TRICREST) | completed | Phase 2 | 55 | Barts & The London NHS TrustOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT04534075 | Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial(FIDURA) | completed | Phase 3 | 354 | Sahlgrenska University HospitalOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT05141383 | Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy (HOPE)(HOPE) | completed | N/A | 80 | Institut CurieOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT00924027 | A Study of Patients Receiving High-Dose Rate Brachytherapy | completed | Phase 2 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 5, 2025 | clinicaltrials |
| NCT03458247 | Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer(OPTIMABI) | completed | Phase 2 | 94 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 5, 2025 | clinicaltrials |
| NCT07156747 | The Impact of Video Education on Pain and Anxiety in Patients Undergoing Transrectal Ultrasonography-Guided Prostate Biopsy(TRUS) | completed | N/A | 223 | Ankara Etlik City HospitalOTHER_GOV | 1 | Sep 5, 2025 | clinicaltrials |
| NCT02470897 | Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate Cancer | completed | N/A | 115 | University of Wisconsin, MadisonOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT05946603 | IS-002 Phase 2 Prostate Cancer Study | completed | Phase 2 | 59 | Intuitive SurgicalINDUSTRY | 1 | Sep 4, 2025 | clinicaltrials |
| NCT03967080 | Adaptive Radiotherapy for High-risk Prostate Cancer Using Multiparametric MRI(ARPC-MRI) | completed | — | 5 | East and North Hertfordshire NHS TrustOTHER_GOV | 1 | Sep 3, 2025 | clinicaltrials |
| NCT06703996 | InBody Band 3 Fitness Tracker to Improve Health Outcomes and Quality of Life in Black Prostate Cancer Survivors | completed | N/A | 13 | Mayo ClinicOTHER | 1 | Sep 3, 2025 | clinicaltrials |
| NCT03275181 | Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer | completed | — | 18 | Kansas State UniversityOTHER | 1 | Sep 2, 2025 | clinicaltrials |
| NCT01368055 | Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer(PR07) | completed | N/A | 361 | University of FloridaOTHER | 1 | Aug 29, 2025 | clinicaltrials |
| NCT04576871 | Re-treatment 225Ac-J591 for mCRPC | completed | Early Phase 1 | 6 | Weill Medical College of Cornell UniversityOTHER | 1 | Aug 28, 2025 | clinicaltrials |
| NCT06582849 | Enhanced Assistance During Radiotherapy for Unmet Essential Needs(EARN) | completed | N/A | 33 | Washington University School of MedicineOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT02874014 | Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate Cancer | completed | Phase 2 | 56 | Mayo ClinicOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT07134504 | Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico. | completed | — | 1 | Instituto Mexicano del Seguro SocialOTHER_GOV | 1 | Aug 21, 2025 | clinicaltrials |
| NCT05533515 | Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of Cancer(C-ProMeta-1) | completed | — | 330 | Queen Mary University of LondonOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT06281769 | Prostate Cancer Detection Rate of Targeted Biopsies With PCaVision | completed | N/A | 467 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT04666129 | Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 48 | Sumitomo Pharma America, Inc.INDUSTRY | 1 | Aug 17, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Oct 31, 2025source: clinicaltrials